Unresectable prostate cancer
Showing 9951 - 9975 of >10,000
Care Giver, Recurrent Malignant Tumor, Refractory Malignant Tumor Trial in Nashville (Internet-Based Intervention, Best
Completed
- Care Giver
- +2 more
- Internet-Based Intervention
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jan 28, 2023
Oncologic Complications Trial in New York (Destek V4 Virtual Reality Headset)
Withdrawn
- Oncologic Complications
- Destek V4 Virtual Reality Headset
- (no location specified)
Oct 7, 2022
Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in India (Bevacizumab)
Recruiting
- Ovarian Neoplasms
- +2 more
-
Vijayawada, Andhra Pradesh, India
- +24 more
Apr 1, 2022
Change in Mood, Change in Personality Trial in Haskovo (Undenatured beta-glucan solution, Placebo)
Recruiting
- Change in Mood
- Change in Personality
- Undenatured beta-glucan solution
- Placebo
-
Haskovo, BulgariaCLINECA EAD Hospital
Jul 18, 2023
Cancer, Cancer Survivors, Informal Caregivers Trial in Tucson (Adaptive Symptom Management and Survivorship Handbook (SMSH) and
Recruiting
- Cancer
- +3 more
- Adaptive Symptom Management and Survivorship Handbook (SMSH) and Telephone Interpersonal Counseling (TIP-C)
- NCI Brochure
-
Tucson, ArizonaUniversity of Arizona
Sep 2, 2022
Adjuvant Radiotherapy for pT1b Esophageal Cancer After
Completed
- Esophageal Cancer
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Aug 10, 2022
Resectable Pancreatic Cancer With Biliary Obstruction Trial in Seoul (ERCP using plastic stent, ERCP using metal stent)
Not yet recruiting
- Resectable Pancreatic Cancer With Biliary Obstruction
- ERCP using plastic stent
- ERCP using metal stent
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
May 28, 2021
Breast Cancer Trial (GSK3326595)
Completed
- Breast Cancer
-
London, Ontario, CanadaSt. Joseph's Health Care London
Oct 24, 2022
Cancer Trial in Aurora (Educational Intervention)
Recruiting
- Cancer
- Educational Intervention
-
Aurora, ColoradoUniversity of Colorado Hospital
Jun 29, 2022
Circulating Tumor DNA and Immunophenotyping as Potential
Recruiting
- Breast Cancer
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 7, 2022
French National Observatory of Non-small Cell Lung and Molecular
Completed
- Carcinoma, Non-Small-Cell Lung
- +3 more
-
Agen, France
- +132 more
Jun 29, 2022
Colorectal Cancer Trial in Strasbourg (Intraoperative acquisition (robotic c-Arm) of images)
Recruiting
- Colorectal Cancer
- Intraoperative acquisition (robotic c-Arm) of images
-
Strasbourg, FranceService de Chirurgie Digestive et Endocrinienne, NHC
Aug 18, 2022
CANCER Trial (APA and nutrition intervention)
Not yet recruiting
- CANCER
- APA and nutrition intervention
- (no location specified)
Jul 1, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Necitumumab
- Osimertinib
-
Duarte, California
- +14 more
Jan 27, 2023
Application of Antiosteoporosis Therapy in Osteolysis
Not yet recruiting
- Limb; Fusion
- Complication
- Anti-osteoporosis therapy
-
Zhengzhou, Henan, ChinaDepartment of Bone and Soft Tissue ,Henan Cancer Hospital
Jan 12, 2023
Hormone Treatment-naïve Participants With Prostate Cancer Trial in Japan (TAK-385)
Completed
- Hormone Treatment-naïve Participants With Prostate Cancer
-
Sakura-shi, Chiba, Japan
- +5 more
Apr 17, 2018
Locally Advanced Gastric Cancer Trial in Fuzhou (Camrelizumab, Albumin Taxol, FLOT scheme)
Not yet recruiting
- Locally Advanced Gastric Cancer
- Camrelizumab
- +2 more
-
Fuzhou, Fujian, China
- +1 more
Nov 8, 2022
Breast Cancer, Gastrointestinal Cancer, Hematologic Cancer Trial in Houston (OPTIMISE)
Recruiting
- Breast Cancer
- +2 more
- OPTIMISE
-
Houston, TexasBaylor College of Medicine
May 16, 2022
Traumatic Stress Disorder, Cancer Trial in Nottingham (Narrative Exposure Therapy)
Active, not recruiting
- Traumatic Stress Disorder
- Cancer
- Narrative Exposure Therapy
-
Nottingham, Nottinghamshire, United KingdomThe University of Nottingham
May 18, 2022
Neutrophils to Lymphocytes Ratio in Predicting Response to BCG
Completed
- Urinary Bladder Cancer
- +4 more
- Neutrophil to lymphocyte ratio
-
Cairo, EgyptAin Shams university
Jul 15, 2023
NSCLC Trial in Shanghai (BL-M02D1)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jul 10, 2023
Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and
Not yet recruiting
- Breast Cancer
- Advanced Breast Cancer
- Everolimus 10 mg
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 14, 2023
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +6 more
-
Iowa City, Iowa
- +60 more
Jan 3, 2023
Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023